AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.100
-0.070 (-3.23%)
Aug 7, 2025, 4:00 PM - Market closed
AC Immune Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for AC Immune stock has a target of 12, which predicts a 471.43% increase from the current stock price of 2.1.
Price Target: $12 (+471.43%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 1, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for AC Immune is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +471.43% | May 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +661.90% | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +661.90% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +661.90% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +661.90% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
3.66M
from 27.31M
Decreased by -86.61%
Revenue Next Year
23.16M
from 3.66M
Increased by 533.21%
EPS This Year
-0.78
from -0.51
EPS Next Year
-0.63
from -0.78
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3M | 33.3M | 117.1M | ||
| Avg | 3.7M | 23.2M | 104.7M | ||
| Low | 980,000 | 13.4M | 91.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -76.9% | 809.9% | 405.5% | ||
| Avg | -86.6% | 533.2% | 352.1% | ||
| Low | -96.4% | 267.5% | 296.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.74 | -0.63 | 0.11 | ||
| Avg | -0.78 | -0.63 | 0.10 | ||
| Low | -0.78 | -0.63 | 0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.